Fast HPLC Method for the Determination of Ketoprofen in Human Plasma Using a Monolithic Column and its Application to a Comparative Bioavailability Study in Man

Abstract

A fast, specific, accurate, precise and reproducible high-performance liquid chromatography (HPLC) method with diode-array detector (DAD) was developed and validated for the determination of ketoprofen (CAS 22071-15-4) in human plasma using flubiprofen (CAS 5104-49-4) as an internal standard. The chromatographic separation was achieved on an onyx monolithic C₁₈ (100Ε4.6 mm) analytical column with an isocratic mobile phase consisting of acetonitrile/potassium dihydrogen phosphate (KH₂PO₄) 0.01 M, (40:60, v/v) adjusted to pH 3.5. The flow was set at 5 ml • min⁻¹ and the wavelength at 254 nm. The total analysis time was less than 5 min. The ratio of peak area of analyte to internal standard was used for quantification. The limit of detection was defined as the ketoprofen concentration that produced a signal-to noise ratio greater than 3. The lower limit of quantification (LLOQ) was 10 ng • ml ⁻¹. At this level, the relative standard deviation (RSD) was lower than 13%. The calibration curve was linear over the concentration range 1–500 ng • ml ⁻¹ with a minimum detectable limit of 10 ng • ml ⁻¹. The coefficients of variation for the interday and intra-day assay were found to be less than 11%. The present method was successfully applied to the routine analysis of human plasma samples collected from healthy volunteers after dermal application of two topical formulations containing ketoprofen in order to assess the relative bioavailability and to demonstrate that the systemic bioavailability of ketoprofen administered topically is low enough to ensure a low incidence of gastrointestinal adverse events.

Key words

CAS 5104-49-4 - CAS 22071-15-4 - Flurbiprofen - Ketoprofen, bioavailability, determination, - HPLC method, plaster - ■ Non-steroidal anti-inflamma tory drugs

• References

• 1 Lazzaroni M, Bianchi Porro G. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Aliment Pharmacol Ther. 2004; 20 (Suppl. 2:) 48-58
• 2 Wolfe MM, Lichtenstein MD, Singh MD. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999; 340 (24) 1888-1899
• 3 Hawkey CJ. Nonsteroidal anti-inflammatory drug gastropathy. Gastroenterol. 2000; 119 (2) 521-535
• 4 Heo SK, Cho J, Cheon JW, Choi MK, Im DS, Kim JJ et al. Pharmacokinetics and Pharmacodinamics of Ketoprofen Plasters. Biopharm Drug Dispos. 2008; 29: 37-44
• 5 Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000; 60 (3) 555-574
• 6 World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subject. 52nd WMA General Assembly, Edinburgh, Scotland, October 2000.
• 7 The European Agency for the Evaluation of Medicinal Products. Note for Guidance on Good Clinical Practice. July 2002. CPMP/ICH/135/95.
• 8 Note for Guidance on the Investigation of Bioavailability and Bioequivalence Committee for Proprietary Medicinal Products. CPMP/EWP/QWP/1401/98, London 26 July 2001.
• 9 Roda A, Sabatini L, Mirasoli M, Baraldini M, Roda E. Bioavailability of a new ketoprofen formulation for once-daily oral administration. Int J Pharm. 2002; 241 (1) 165-172
• 10 Panusa A, Multari G, Incarnato G, Gagliardi L. High-performance liquid chromatography analysis of anti-inflammatory pharmaceuticals with ultraviolet and electrospraymass spectrometry detection in suspected counterfeit homeopathic medicinal products. J Pharm Biomed Anal. 2004; 43 (4) 1221-1227
• 11 Bempong DK, Bhattacharyya L. Development and validation of a stability-indicating high-performance liquid chromatographic assay for ketoprofen topical penetrating gel. J Chromatogr A. 2005; 1073 (1–2) 341-346
• 12 Kocyiğit-Kaymakcoğlu B, Unsalan S, Rollas S. Determination and validation of ketoprofen, pantoprazole and valsartan together in human plasma by high performance liquid chromatography. Pharmazie. 2006; 61 (7) 586-589
• 13 Owen SG, Roberts MS, Friesen WT. Rapid high-performance liquid chromatographic assay for the simultaneous analysis of non-steroidal anti-inflammatory drugs in plasma. J Chromatogr. 1987; 416: 293-302
• 13 Pickl KE, Magnes C, Bodenlenz M, Pieber TR, Sinner FM. Rapid online-SPE-MS/MS method for ketoprofen determination in dermal interstitial fluid samples from rats obtained by microdialysis or open-flow microperfusion. J Chromatogr B. 2007; Analyt Technol Biomed Life Sci. 850 (1–2) 432-439
• 15 Vinci F, Fabbrocino S, Fiori M, Serpe L, Gallo P. Determination of fourteen non-steroidal anti-inflammatory drugs in animal serum and plasma by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom. 2006; 20 (22) 3412-3420
• 16 Nováková L, Matysová L, Solichová D, Koupparis MA, Solich P. Comparison of performance of C18 monolithic rod columns and conventional C18 particle-packed columns in liquid chromatographic determination of Estrogel and Ketoprofen gel. J Chromatogr B. 2004; Analyt Technol Biomed Life Sci. 813 (1–2) 191-197
• 17 Yin-Xiu Jin, Yi-Hong Tang, Su Zeng. Analysis of flurbiprofen, ketoprofen and etodolac enantiomers by pre-column derivatization RP-HPLC and application to drug-protein binding in human plasma. J Pharm Biomed Anal. 2008; 4: 6953-6958
• 18 Mazières B. Topical ketoprofen patch. Drugs. 2005; 6: 337-344
• 19 Flouvat B, Roux A, Delhotai-Landes B. Pharmacokinetics of ketoprofen in man after repearted percutaneous administration. Arzneimittelforschung. 1989; 39 (7) 812-813